Involvement of GABA systems in feedback regulation of glutamate‐and GABA‐mediated synaptic potentials in rat neostriatum.

1. Neostriatal neurones were recorded intracellularly from a rat corticostriatal slice preparation. Depolarizing postsynaptic potentials (DPSPs) were evoked by either cortical or intrastriatal stimulation. 2. Kynurenic acid (600 microM), an antagonist of excitatory amino acids, reduced the cortically‐evoked DPSPs by 88% while the intrastriatally evoked potentials were reduced by 48%. Bicuculline (100 microM) produced only a slight inhibition of the cortically evoked DPSPs (12%), but clearly depressed intrastriatal potentials (52%). 3. The effects of (‐)‐baclofen, a gamma‐aminobutyric acid (GABA)B receptor agonist, were studied on the cortically evoked DPSPs. In all the tested neurones (‐)‐baclofen, added to the superfusion medium, caused a concentration‐dependent decrease of these potentials (half‐maximal effect (EC50) = 800 nM). This effect was not affected by bicuculline. (‐)‐Baclofen did not change the membrane potential, the input resistance, current‐evoked firing frequency, or postsynaptic responses to exogenously applied glutamate. 4. The effects of (‐)‐baclofen on the DPSPs were compared to those produced by application of GABA and muscimol. GABA and muscimol decreased the DPSPs and caused a membrane depolarization coupled with a decrease of the membrane resistance. Bicuculline (100 microM) blocked the GABA‐induced changes of the membrane potential and of the resistance, but not the decrease of the synaptic potentials. All the effects produced by muscimol were blocked by bicuculline. 5. Following intrastriatal stimulation a residual kynurenate‐insensitive potential persisted; this potential was blocked by bicuculline (100 microM). (‐)‐Baclofen produced a dose‐dependent decrease of this potential (EC50 = 800 nM). The postsynaptic responses to exogenously applied GABA were unchanged by (‐)‐baclofen. 6. The amplitude of kynurenate and bicuculline‐sensitive DPSPs were stable at a frequency of 0.1 Hz. At frequencies between 0.3 and 3 Hz both these potentials were attenuated with the second stimulus and after about five stimuli a steady state was reached. Membrane potential and input resistance were not affected by these frequencies of stimulation. 7. Application of the GABA uptake inhibitor nipecotic acid (100‐300 microM) clearly reduced the amplitude of both kynurenate‐and bicuculline‐sensitive DPSPs evoked at low frequencies of stimulation (0.01‐0.3 Hz), but had lower effects at higher stimulation rates (1‐3 Hz). Application of nipecotic acid increased the duration of membrane responses to exogenously applied GABA.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  P. Calabresi,et al.  Endogenous GABA mediates presynaptic inhibition of spontaneous and evoked excitatory synaptic potentials in the rat neostriatum , 1990, Neuroscience Letters.

[2]  A. Meli,et al.  Intracerebroventricular phaclofen antagonizes baclofen antinociceptive activity in hot plate test with mice. , 1988, European journal of pharmacology.

[3]  C. Scholfield.  Baclofen blocks postsynaptic inhibition but not the effect of muscimol in the olfactory cortex , 1983, British journal of pharmacology.

[4]  J. Olney.  Excitatory amino acids and neuropsychiatrie disorders , 1989, Biological Psychiatry.

[5]  P. Groves.  A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement , 1983, Brain Research Reviews.

[6]  Charles J. Wilson,et al.  Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: A study employing intracellular injection of horseradish peroxidase , 1980 .

[7]  D. A. Brown,et al.  GABAB-receptor-activated K+ current in voltage-clamped CA3 pyramidal cells in hippocampal cultures. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Dunlap.  TWO TYPES OF γ‐AMINOBUTYRIC ACID RECEPTOR ON EMBRYONIC SENSORY NEURONES , 1981 .

[9]  D. Middlemiss,et al.  (–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor , 1980, Nature.

[10]  G Bernardi,et al.  Synaptic and intrinsic control of membrane excitability of neostriatal neurons. II. An in vitro analysis. , 1990, Journal of neurophysiology.

[11]  N. Bowery,et al.  GABAA and GABAB receptor site distribution in the rat central nervous system , 1987, Neuroscience.

[12]  D. Prince,et al.  Frequency‐dependent depression of inhibition in guinea‐pig neocortex in vitro by GABAB receptor feed‐back on GABA release. , 1989, The Journal of physiology.

[13]  B H Gähwiler,et al.  Activity-dependent disinhibition. III. Desensitization and GABAB receptor-mediated presynaptic inhibition in the hippocampus in vitro. , 1989, Journal of neurophysiology.

[14]  G Bernardi,et al.  Synaptic and intrinsic control of membrane excitability of neostriatal neurons. I. An in vivo analysis. , 1990, Journal of neurophysiology.

[15]  P. Calabresi,et al.  Intrinsic membrane properties of neostriatal neurons can account for their low level of spontaneous activity , 1987, Neuroscience.

[16]  P. Calabresi,et al.  Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: Intracellular studies from naive and catecholamine-depleted rats , 1988, Neuroscience.

[17]  N. Mercuri,et al.  On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. , 1988, The Journal of physiology.

[18]  M. Cuénod,et al.  Glutamate release in vitro from corticostriatal terminals , 1979, Brain Research.

[19]  L. Iversen,et al.  Alterations of brain neurotransmitter receptor binding in Huntington's chorea , 1976, Brain Research.

[20]  W Zieglgänsberger,et al.  Baclofen reduces post‐synaptic potentials of rat cortical neurones by an action other than its hyperpolarizing action. , 1987, The Journal of physiology.

[21]  B. Gähwiler,et al.  Activity-dependent disinhibition. I. Repetitive stimulation reduces IPSP driving force and conductance in the hippocampus in vitro. , 1989, Journal of neurophysiology.

[22]  P. Calabresi,et al.  Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: Evidence for D1 receptor involvement , 1987, Neuroscience.

[23]  Hugh J. Spencer.  Antagonism of cortical excitation of striatal neurons by glutamic acid diethyl ester: Evidence for glutamic acid as an excitatory transmitter in the rat striatum , 1976, Brain Research.

[24]  R. Nicoll,et al.  Pre- and postsynaptic GABAB receptors in the hippocampus have different pharmacological properties , 1988, Neuron.

[25]  G. Graveland,et al.  Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.

[26]  I. Divac,et al.  High affinity uptake of glutamate in terminals of corticostriatal axons , 1977, Nature.

[27]  D. Kerr,et al.  2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABAB receptors , 1988, Neuroscience Letters.

[28]  J. Olney.  Excitatory amino acids and neuropsychiatric disorders. , 1989, Biological psychiatry.

[29]  P. Stanzione,et al.  Excitatory amino acids in synaptic excitation of rat striatal neurones in vitro. , 1988, The Journal of physiology.

[30]  R. Nicoll,et al.  Direct hyperpolarizing action of baclofen on hippocampal pyramidal cells , 1984, Nature.

[31]  M. Ebadi,et al.  Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia , 1988, Neuroscience & Biobehavioral Reviews.

[32]  S. T. Kitai,et al.  A Golgi study of rat neostriatal neurons: Light microscopic analysis , 1982, The Journal of comparative neurology.

[33]  P. Calabresi,et al.  Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording , 1989, British journal of pharmacology.

[34]  J. Nadler,et al.  Baclofen selectively inhibits transmission at synapses made by axons of CA3 pyramidal cells in the hippocampal slice. , 1982, The Journal of pharmacology and experimental therapeutics.

[35]  R. Nicoll,et al.  A physiological role for GABAB receptors in the central nervous system , 1988, Nature.

[36]  S. T. Kitai,et al.  Medium spiny neuron projection from the rat striatum: An intracellular horseradish peroxidase study , 1980, Brain Research.

[37]  M. Raiteri,et al.  Release‐regulating autoreceptors of the GABAB‐type in human cerebral cortex , 1989, British journal of pharmacology.

[38]  N. Bowery.  GABAB receptors and their significance in mammalian pharmacology. , 1989, Trends in pharmacological sciences.

[39]  N. Dun,et al.  Phaclofen‐insensitive presynaptic inhibitory action of (±)‐baclofen in neonatal rat motoneurones in vitro , 1990, British journal of pharmacology.

[40]  M. Kupersmith,et al.  The effect of decortication on the basal ganglia GABA receptor , 1980, Neuroscience Letters.

[41]  A. Dolphin,et al.  Calcium channel currents and their inhibition by (‐)‐baclofen in rat sensory neurones: modulation by guanine nucleotides. , 1987, The Journal of physiology.

[42]  S N Davies,et al.  Paired‐pulse depression of monosynaptic GABA‐mediated inhibitory postsynaptic responses in rat hippocampus. , 1990, The Journal of physiology.